| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1600-6143.2009.03001.X |
| P8608 | Fatcat ID | release_6bsuegxyfncszokspjhyynahai |
| P698 | PubMed publication ID | 20121749 |
| P5875 | ResearchGate publication ID | 227762122 |
| P2093 | author name string | R A Montgomery | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | desensitization | Q2700499 |
| antibody | Q79460 | ||
| P304 | page(s) | 449-457 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols | |
| P478 | volume | 10 |
| Q84647401 | A possible system for optimal donor kidney exchange in Turkey |
| Q35607565 | ABO Incompatible Kidney Transplantation-Current Status and Uncertainties |
| Q42378543 | ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report |
| Q36696495 | ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier. |
| Q38151236 | Allocation and matching in kidney exchange programs |
| Q52401610 | Antibody-mediated rejection: New approaches in prevention and management. |
| Q30277267 | Approach to the Highly Sensitized Kidney Transplant Candidate |
| Q34189435 | Bortezomib in kidney transplantation |
| Q47558999 | Case Report of Kidney Paired Donation (KPD) with Desensitization: the Strategy and Experience of 3-Way KPD in Samsung Medical Center |
| Q47313617 | Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q38476939 | Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation |
| Q37836967 | Current approaches to the management of highly sensitized kidney transplant patients |
| Q36171175 | Current progress in ABO-incompatible kidney transplantation |
| Q36586705 | Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases. |
| Q86591832 | Desensitization in ABO-Incompatible Kidney Transplantation With Low ABO Iso-Agglutinin Titers |
| Q41731036 | Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy |
| Q37428551 | Essential concept of transplant immunology for clinical practice |
| Q30276550 | Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue |
| Q46153238 | HLA high-resolution typing for sensitized patients: a solution in search of a problem? |
| Q89472835 | HLA in transplantation |
| Q38036246 | Incompatible kidney transplantation: a brief overview of the past, present and future. |
| Q37345356 | Increasing access to kidney transplantation for sensitized recipient through three-way kidney paired donation with desensitization: The first Indian report |
| Q38006827 | Innovative strategies in living donor kidney transplantation |
| Q44853598 | Is it ethical to invite compatible pairs to participate in exchange programmes? |
| Q45049198 | Kidney Exchange to Overcome Financial Barriers to Kidney Transplantation. |
| Q55505638 | Kidney exchange transplantation current status, an update and future perspectives. |
| Q38258064 | Kidney paired donation: principles, protocols and programs |
| Q39173951 | Kidney paired exchange and desensitization: Strategies to transplant the difficult to match kidney patients with living donors |
| Q50137555 | Landscape of ABO-Incompatible Live Donor Kidney Transplantation in the US. |
| Q44392077 | Long-term outcome of highly sensitized African American patients transplanted with deceased donor kidneys |
| Q48258344 | Marginal organ allocation: old and new REALity |
| Q38172280 | Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation |
| Q53610974 | Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition. |
| Q42229870 | Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience. |
| Q92263435 | Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience |
| Q44265489 | Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients |
| Q40245497 | Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study |
| Q35822937 | Outcomes of ABO-incompatible kidney transplantation in the United States |
| Q45719154 | Paired kidney donation: a (virtual) balancing act. |
| Q38010231 | Prevention of antibody-mediated kidney transplant rejection |
| Q30557870 | Protocol of a cluster randomized trial of an educational intervention to increase knowledge of living donor kidney transplant among potential transplant candidates |
| Q38030174 | Recent developments in desensitization of crossmatch-positive kidney transplant recipients |
| Q44911053 | Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma |
| Q40523283 | Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab |
| Q49332019 | Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin. |
| Q36827985 | Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. |
| Q50950214 | The effectiveness of the combination of rituximab and high-dose immunoglobulin in the immunomodulation of sensitized kidney transplant candidates. |
| Q34106158 | The generation and maintenance of serum alloantibody. |
| Q38258153 | The increasing clinical importance of alloantibodies in kidney transplantation |
| Q50062896 | The mechanisms of rejection in solid organ transplantation |
| Q83396297 | The utilization and advantages of an exchange donor program in living donor renal transplantation: a single-center experience |
| Q30456482 | Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine |
| Q26778752 | Translational research in kidney transplantation and the role of patient engagement |
| Q85040734 | Transplantation: Desensitization and transplantation for sensitized patients? |
| Q46583356 | Transplantation: Survival benefits of incompatible living donor kidney transplants |
Search more.